相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。p38-regulated FOXC1 stability is required for colorectal cancer metastasis
Yi Zhang et al.
JOURNAL OF PATHOLOGY (2020)
Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis
Marion Curtis et al.
CELL METABOLISM (2019)
Contribution of epithelial-mesenchymal transitions to organogenesis and cancer metastasis
Kyra Campbell
CURRENT OPINION IN CELL BIOLOGY (2018)
Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes
Arthur Winer et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Time-course transcriptome analysis of medullary thymic epithelial cells in the early phase of thymic involution
Haoming Wu et al.
MOLECULAR IMMUNOLOGY (2018)
MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancer
Sylwia Gawrzak et al.
NATURE CELL BIOLOGY (2018)
Cell-Autonomous Metabolic Reprogramming in Hypoxia
Luana Schito et al.
TRENDS IN CELL BIOLOGY (2018)
Quantitative in vivo whole genome motility screen reveals novel therapeutic targets to block cancer metastasis
Konstantin Stoletov et al.
NATURE COMMUNICATIONS (2018)
Positive correlation between postoperative tumor recurrence and changes in circulating tumor cell counts in pulmonary venous blood (pvCTC) during surgical manipulation in non-small cell lung cancer
Masaki Hashimoto et al.
JOURNAL OF THORACIC DISEASE (2018)
New Directions in the Study and Treatment of Metastatic Cancer
Byunghee Yoo et al.
FRONTIERS IN ONCOLOGY (2018)
Dissemination from a Solid Tumor: Examining the Multiple Parallel Pathways
Moriah E. Katt et al.
TRENDS IN CANCER (2018)
Genome-wide in vivo screen identifies novel host regulators of metastatic colonization
Louise van der Weyden et al.
NATURE (2017)
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
Hashem O. Alsaab et al.
FRONTIERS IN PHARMACOLOGY (2017)
Surgery for Cancer: A Trigger for Metastases
Samer Tohme et al.
CANCER RESEARCH (2017)
mTOR Signaling in Growth, Metabolism, and Disease
Robert A. Saxton et al.
CELL (2017)
Hypoxic control of metastasis
Erinn B. Rankin et al.
SCIENCE (2016)
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
Luana Schito et al.
TRENDS IN CANCER (2016)
Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis
Amal M. El-Naggar et al.
CANCER CELL (2015)
Exploiting the critical perioperative period to improve long-term cancer outcomes
Maya Horowitz et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Clinicopathological Characteristics of Gynecological Cancer Associated with Hypoxia-Inducible Factor 1α Expression: A Meta-Analysis Including 6,612 Subjects
Yue Jin et al.
PLOS ONE (2015)
UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1α
Yoko Goto et al.
NATURE COMMUNICATIONS (2015)
HIF-1α pathway: role, regulation and intervention for cancer therapy
Georgina N. Masoud et al.
ACTA PHARMACEUTICA SINICA B (2015)
HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor
Simona Pavan et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Hypoxia inducible factor-1 alpha plays a pivotal role in hepatic metastasis of pancreatic cancer: an immunohistochemical study
Yoichiro Matsuo et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2014)
Clinicopathological and prognostic significance of hypoxia-inducible factor-1α in esophageal squamous cell carcinoma: a meta-analysis
Wei Ping et al.
TUMOR BIOLOGY (2014)
Oral administration of GLPG0259, an inhibitor of MAPKAPK5, a new target for the treatment of rheumatoid arthritis: a phase II, randomised, double-blind, placebo-controlled, multicentre trial
Rene Westhovens et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
MK5 activates Rag transcription via Foxo1 in developing B cells
Kwan T. Chow et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Pharmacokinetics, Safety, and Tolerability of GLPG0259, a Mitogen-Activated Protein Kinase-Activated Protein Kinase 5 (MAPKAPK5) Inhibitor, Given as Single and Multiple Doses to Healthy Male Subjects
Florence Namour et al.
Drugs in research & development (2013)
Discovery of a series of imidazopyrazine small molecule inhibitors of the kinase MAPKAPK5, that show activity using in vitro and in vivo models of rheumatoid arthritis
Martin J. I. Andrews et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling
Nadine Stoehr et al.
GENES & DEVELOPMENT (2012)
A Novel Function of p38-Regulated/Activated Kinase in Endothelial Cell Migration and Tumor Angiogenesis
Naoto Yoshizuka et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
PRAK Suppresses Oncogenic ras-Induced Hematopoietic Cancer Development by Antagonizing the JNK Pathway
Naoto Yoshizuka et al.
MOLECULAR CANCER RESEARCH (2012)
被撤回的出版物: HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs (Retracted article. See MAY, 2023)
H. Zhang et al.
ONCOGENE (2012)
The diterpenoid alkaloid noroxoaconitine is a Mapkap kinase 5 (MK5/PRAK) inhibitor
Sergiy Kostenko et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
The MK5/PRAK Kinase and Myc Form a Negative Feedback Loop that Is Disrupted during Colorectal Tumorigenesis
Theresia R. Kress et al.
MOLECULAR CELL (2011)
Inactivation of Rheb by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1
Min Zheng et al.
NATURE CELL BIOLOGY (2011)
The Kinase Inhibitor SFV785 Dislocates Dengue Virus Envelope Protein from the Replication Complex and Blocks Virus Assembly
Azlinda Anwar et al.
PLOS ONE (2011)
Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
Carmen Chak-Lui Wong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
John M. L. Ebos et al.
CANCER CELL (2009)
Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology
Sergiy Kostenko et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Metastasis: from dissemination to organ-specific colonization
Don X. Nguyen et al.
NATURE REVIEWS CANCER (2009)
Microenvironmental regulation of metastasis
Johanna A. Joyce et al.
NATURE REVIEWS CANCER (2009)
Hypoxia-inducible Factor 1α Mediates Anoikis Resistance via Suppression of α5 Integrin
Nadine Rohwer et al.
CANCER RESEARCH (2008)
RNA-Binding proteins HuR and PTB promote the translation of hypoxia-inducible factor 1 alpha
Stefanie Galban et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Modulation of F-actin rearrangement by the cyclic AMP/cAMP-dependent protein kinase (PKA) pathway is mediated by MAPK-activated protein kinase 5 and requires PKA-induced nuclear export of MK5
Nancy Gerits et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
14-3-3epsilon inhibits MK5-mediated cell migration by disrupting F-actin polymerization
Heejae Tak et al.
CELLULAR SIGNALLING (2007)
PRAK is essential for ras-induced senescence and tumor suppression
Peiqing Sun et al.
CELL (2007)
Hypoxia-inducible factor-1α is a key regulator of metastasis in a transgenic model of cancer initiation and progression
Debbie Liao et al.
CANCER RESEARCH (2007)
被撤回的出版物: Lysyl oxidase is essential for hypoxia-induced metastasis (Retracted article. See vol. 579, pg. 456, 2020)
JT Erler et al.
NATURE (2006)
Metastasis: a question of life or death
P Mehlen et al.
NATURE REVIEWS CANCER (2006)
Identification of a motif that mediates polypyrimidine tract-binding protein-dependent internal ribosome entry
SA Mitchell et al.
GENES & DEVELOPMENT (2005)
Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases
M Koch et al.
ANNALS OF SURGERY (2005)
Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases
EY Lin et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)